* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Alcohol and Other Drug Emergencies
Drug interaction wikipedia , lookup
Drug design wikipedia , lookup
Drug discovery wikipedia , lookup
Effects of long-term benzodiazepine use wikipedia , lookup
Neuropharmacology wikipedia , lookup
Pharmacokinetics wikipedia , lookup
Polysubstance dependence wikipedia , lookup
Alcohol and Other Drug Emergencies EMC SDMH 2015 Objectives • Recognise and manage alcohol and opioid overdose • Recognise and manage stimulant toxicity • Become familiar with dealing with severe alcohol withdrawal and acute complications of alcohol addiction • Recognise and manage opioid withdrawal • Develop an approach to ED assessment of less acute alcohol related and appropriate referral AOD and the ED • Data lacking for amount of presentations to ED • Point estimates 13.8% pt’s in ED relating to alcohol during high demand times • 8% average rate of alcohol related presentations • Drug reporting absent – anecdotally increasing • Frequent crisis presentations – interventions? Alcohol overdose • Occasionally seen • Possible cardio-respiratory depression with sudden elevations to high levels • BAL 0.4-0.5 in naïve individuals • Risk of aspiration with drop in GCS • Typically young males ‘sculling’ spirits • Watch for hypoglycaemia Opioid overdose • Uncommon to get to ED – ASNSW • Changing patterns of opioids • Death from respiratory depression • Resp. depression, miosis and hx of drug exposure suggest diagnosis • Naloxone 0.4 -2 mg IV/IM/IN reverses effects for 20-90 mins. • May provoke withdrawal ! • Larger doses may be required for SR formulations, fentanyl and methadone • May require infusion in above situation Stimulant overdose • Amphetamine, cocaine, MDMA, methamphetamine • Toxic usage - may only be 1-2 x ‘normal’ use • Sympathomimetic toxidrome • Methamphetamine – CNS excitation, paranoia, psychosis common • IV benzodiazepines to sedate +/fluids. • Hyperthermia indicates severe toxicity and requires aggressive management • IM/IV droperidol for behavioural disturbance may also be useful Alcohol withdrawal • Crisis presentations (unplanned abstinence) • Occurrence during intercurrent illness/admission • Request for ‘detox’ after bingeing • Onset 6-24 from last drink. • Withdrawal possible with positive BAL Symptoms/Signs of alcohol withdrawal • Withdrawal seizure may be presenting complaint Severe withdrawal • Seizures – 2-9%; occur within first 48 hrs Anticonvulsants ineffective for acute alcoholic seizures – use benzodiazepines. • Alcohol withdrawal delirium (‘delirium tremens’) – 5% • Hallucinations • Requires inpatient supervision and management to prevent mortality Management • Benzodiazepines mainstay of therapy Diazepam standard agent Oxazepam if concerns regarding age, hepatic function • Dosing by differing approaches ‘Loading dose’ – 20mg q 2-4 hr until 80mg reached, then cease and observe ‘Tapered’ 10-20mg qid, reducing on daily basis ‘Symptom triggered’ – PRN dosing basis upon an AWS NB – What does a febrile rigoring pneumonia pt score on the AWS? Wernickes encephalopathy • Classic triad rarely present • ~12.5% heavy drinkers (by autopsy studies) • Nonspecific confusion and STM loss often only signs. • Confabulation = classic feature of Dx • Failure to diagnose leads to irreversible neurological changes (Korsakoff’s syndrome) • In malnourished/severe alcoholism parenteral thiamine required (bioavailability 1.5%!) • IMI Thiamine 300mg daily for 3-5 days, then PO for further 1-2 weeks Other problems • Malnourishment • Dehydration • Electrolytes – K, Mg • Hypoglycemia/Ketosis • Arrhythmias' – AF • Infection • Trauma - falls Opioid Withdrawal • Uncommon (currently) • May present with drug–seeking behaviour • ‘Acute abdomen’ – cramps, pains, vomiting • Loud ! • Presence track marks; yawning; goosebumps typical features • Pt may disclose hx of drug use and request withdrawal assistance Opioid Withdrawal • Onset time dependent upon drug of abuse • Aim to reduce symptoms whilst attempting to engage in controlled withdrawal • Illegal to knowingly prescribe opioids to known addicts for purposes of withdrawal management without specific authority • Permitted to prescribe for pain for medical illness Opioid withdrawal • Buprenorphine SL is preferred agent of choice 4-8 mg SL daily Binds m receptors, long acting, higher affinity than other opioid Partial agonist so lower risk overdose • If unable to prescribe buprenorphine, then symptomatic management undertaken Ongoing management • Detailed assessment of drug habit(s) • Engagement with family and social supports • Counselling services • AOD community services Questions Summary • Patterns of opioid use changing dramatically; be aware of novel opioid overdoses • Stimulant overdose potentially fatal but uncommon. Psychosis common • Alcohol withdrawal mortality virtually zero with early decisive care. • Wernicke's encephalopathy under-recognized. Give all alcoholic pt.'s parenteral thiamine • Ensure other health issues have been attended to and that correct diagnosis applied • Acute opioid withdrawal less common than previously – can be problematic to control in ED without authorized prescribers • All AOD presentations will benefit from brief interventions to try and engage with withdrawal management in community